CRNX Crinetics Pharmaceuticals, Inc. Loading...

Loading chart...
Top Calls

No data yet

Price change since each call, adjusted for long/short direction. Results calculated:

Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
Time Author Thesis Company / ticker Signal Since call Position Source
09:20
Jan 24
u/DrinkConscious9173
r/biotech_stocks
Long CRNX ahead of PDUFA with 98% ML score.
The author's ML model holds CRNX long ahead of a PDUFA catalyst in 35 days, assigning a 98% confidence score for a positive catalyst outcome. A favorable FDA decision could push the stock toward the $64.49 target; the trade is invalidated below the $51.59 stop loss.
CRNX Crinetics Pharmaceuticals, Inc. Long 1ST — —
00:56
Jan 17
Jim Cramer CNBC
CNBC
Crinetics is vetted spec biotech.
Crinetics is a better speculation than Aquestive because Goldman Sachs has vetted it with a buy recommendation, it has money, and it is not a low-dollar stock.
CRNX Crinetics Pharmaceuticals, Inc. Long 1ST — —

About CRNX Investor Commentary

Across the available history and selected sources, Buzzberg tracks CRNX (Crinetics Pharmaceuticals, Inc.) across 9 sources: 2 bullish vs 0 bearish calls from 9 authors. Historical directional balance: 12% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 16 total trade ideas tracked. Latest voices: u/DrinkConscious9173, Jim Cramer.